Dr. Suwelack Unternehmensstiftung launches annual award to honor young scientists innovating in regenerative technologies within surgery.
 |
| New annual award from Dr. Suwelack Unternehmensstiftung aims to support and promote groundbreaking research in regenerative technologies by young scientists. |
BILLERBECK, Germany – April 11, 2025:
The Dr. Suwelack Unternehmensstiftung has announced the launch of a prestigious annual award designed to recognize and support young scientists who are making significant strides in the field of regenerative technologies within surgery. The Publication Award seeks to highlight and promote groundbreaking research that has the potential to transform surgical practices and patient outcomes.
This initiative by the Dr. Suwelack Unternehmensstiftung aims to foster innovation and encourage the next generation of leaders in regenerative medicine. Eligible candidates for the award are doctors and scientists up to 40 years of age who have published impactful research within the last two years. The award committee, comprised of distinguished experts from both the Dr. Suwelack Corporate Foundation and MedSkin Solutions Dr. Suwelack AG, will evaluate submissions based on their innovation and potential impact.
"We are excited to launch this award and promote the innovative work of young scientists in regenerative technologies," stated Dr. Isaac Angele, a representative of the Dr. Suwelack Corporate Foundation. The committee, chaired by Prof. Dr. med Adrian Dragu, includes medical and scientific experts Dr. med Volker Schmidt, Dr. med. Britta Wallner, and Dr. med. Enrique Monclús, alongside industry representatives Diana Ferro, Dr. Claudia Doberenz, and Dr. Ali Shahmoradi.
The winner of the Publication Award will be officially announced at the European Tissue Repair Society (ETRS) conference, providing a prominent platform to showcase their pioneering research to a global audience. This announcement underscores the Dr. Suwelack Unternehmensstiftung's commitment to advancing medical science and supporting the development of cutting-edge regenerative technologies.